Envision Energy, a global leader in green technology, showcased its groundbreaking green hydrogen fuel solutions at Singapore Maritime Week, exploring the adoption of green fuel to decarbonize the maritime industry. The Singapore Maritime Week is one of the most prestigious maritime events in Asia, bringing together international and regional leaders from all sectors of the maritime industry.
After a brief dip, oil prices regained some ground on Tuesday, influenced by geopolitical developments in the Middle East. Both US West Texas Intermediate and Brent crude futures saw marginal increases as investors reassessed the supply risks associated with the region. Although hostilities between Israel and Iran had no immediate impact on oil supply, analysts cautioned that the evolving geopolitical landscape remained a key factor influencing prices.
A delegation led by the Chairman of the China Council for the Promotion of International Trade (CCPIT) visited . The visit focused on the China- Business Assembly Forum and a roadshow for the 2nd China International Supply Chain Expo (CISCE). Several agreements were signed, including a memorandum of cooperation and letters of intent for participation in the upcoming expo in November. These agreements mark a further step in the strong trade partnership between the two nations.
Imparta has announced the release of i-Coach AI, the world’s first sales methodology-aware AI. Designed to follow a proven coaching process and fluent in all aspects of sales, i-Coach AI provides targeted coaching and practice simulations based on Imparta’s Agile 3D methodology. Imparta is hosting a webinar on September 14, 2023, to showcase i-Coach AI and discuss essential use cases.
Standard Chartered’s Geoff Kendrick reiterates a price target of $150,000 for Bitcoin by 2024, despite a recent 11% slide. The analyst cites anticipated investor inflows and the post-halving price surge trend. Despite concerns raised by some experts, other analysts remain bullish on Bitcoin’s future prospects.
JNK India Limited’s initial public offering (IPO) opened for subscription on April 23 and will close on April 25 with a price band of ₹395 to ₹415 per equity share. The company aims to raise approximately ₹649.47 crore through this IPO, including ₹300 crore from the issuance of fresh shares and ₹349.47 crore from the offer for sale (OFS).
US markets have continued their downward trend despite strong earnings reports from tech and financial giants. Investors remain cautious due to concerns about inflation, Fed commentary, and a realization that interest rate cuts may be delayed. While companies like Goldman Sachs, Morgan Stanley, United Airlines, Taiwan Semiconductor Manufacturing, and Netflix have exceeded expectations, overall guidance and commentary have been more cautious. Investors are reacting more to tepid CEO commentary than actual results, highlighting uncertainty in the current economic climate. Big tech companies, known as the “Magnificent 7,” are set to release earnings this week, including Tesla, Meta, Microsoft, and Alphabet. Intel is also expected to post strong growth due to demand for generative AI products.
The Indian rupee gained against the US dollar in early trade on Tuesday. The local unit opened at 83.37 against the greenback and later reached 83.30, marking a rise of 6 paise from its previous close. The positive sentiment in domestic equity markets, along with the absence of adverse geopolitical developments, contributed to the rupee’s appreciation.
The inhaled nitric oxide market is projected to grow significantly in the coming years, reaching $1.6 billion by 2032. This growth is primarily attributed to the increasing adoption of inhaled nitric oxide for treating pulmonary disorders in newborns and the rising prevalence of respiratory diseases. The report provides an in-depth analysis of the market, including key drivers, restraints, opportunities, challenges, and competitive landscape.
Vertex Pharmaceuticals has partnered with TreeFrog Therapeutics to obtain an exclusive license to TreeFrog’s proprietary cell manufacturing technology, C-Stem. This collaboration aims to optimize the production of Vertex’s cell therapies for type 1 diabetes (T1D). TreeFrog’s technology is designed to mimic the natural microenvironment, allowing cells to grow exponentially in 3D. By scaling up TreeFrog’s process, Vertex will be able to generate large amounts of fully differentiated cells for its T1D therapies.
